ARGX Snapshot
argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases, hematology and cancer. The company is headquartered in Breda, the Netherlands.
Market Capitalization$14,227,682,000
Price to Sales27.89
Earnings per Share$-7.2400
PE RatioNone
Most Recent Close$276.3200
52 Week High$382.15
52 Week Low$248.21
50-Day Moving Average$300.18
200-Day Moving Average$303.08
All data are from Alpha Vantage as of today. For more infomation on ARGX see Stock Dividend, Valuation, Price and Financial Data for Investors